SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of August 2005
FRESENIUS MEDICAL CARE CORPORATION
-----------------------------------------------
(Translation of registrant's name into English)
Else-Kroner Strasse 1
61346 Bad Homburg
Germany
----------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes [ ] No [X]
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b): 82
This Report on Form 6-K shall be incorporated by reference in the
prospectus, dated July 20, 2005 (the "Prospectus"), of Fresenius Medical Care AG
(the "Company") included in the Company's Registration Statement (Registration
No. 333-124759) on Form F-4 and shall be part thereof from the date on which
this report is filed, to the extent not superseded by documents or reports
subsequently filed or furnished by the Company with the U.S. Securities and
Exchange Commission.
On August 31, 2005, the Company announced that (i) at an extraordinary
general meeting held August 30, 2005, its ordinary shareholders had approved the
previously announced proposals to convert the Company's legal form from a stock
corporation (Aktiengesellschaft) into a partnership limited by shares
(Kommanditgesellschaft auf Aktien) under German law and to offer holders of the
Company's preference shares the right to convert their preference shares into
ordinary shares and (ii) at a separate meeting of preference shareholders held
following the EGM, its preference shareholders had approved the conversion
proposal. A copy of the Company's Investor News release is being furnished with
this report.
EXHIBITS
Exhibit 99. Investor News release issued August 31, 2005
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
DATE: August 31, 2005
FRESENIUS MEDICAL CARE
AKTIENGESELLSCHAFT
By: /s/ BEN LIPPS
-------------------------------------
Name: Dr. Ben Lipps
Title: Chief Executive Officer and
Chairman of the Management Board
By: /s/ LAWRENCE A. ROSEN
-------------------------------------
Name: Lawrence A. Rosen
Title: Chief Financial Officer
3